AI in Drug Discovery

AI is revolutionizing the drug discovery process by shifting from traditional trial-and-error methods to data-driven simulations. By analyzing vast datasets of antibody sequences, AI can generate molecules with a higher likelihood of success, potentially reducing the need for animal testing and improving clinical outcomes. This innovative approach emphasizes the importance of data in identifying effective drug candidates.